Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Golding

Showing results (171-180 of 192) with videos related to

Pageof 20
Sort By:
Organic & Biomolecular Chemistry|June 16, 2007
Structure-based design of 2-arylamino-4-cyclohexylmethoxy-5-nitroso-6-aminopyrimidine inhibitors of cyclin-dependent kinase 2Francesco Marchetti, Kerry L Sayle, Johanne Bentley, et al.
ACS Combinatorial Science|July 12, 2016
High-Throughput Screening and Hit Validation of Extracellular-Related Kinase 5 (ERK5) InhibitorsStephanie M Myers, Ruth H Bawn, Louise C Bisset, et al.
Journal of Medicinal Chemistry|October 13, 2006
Small-molecule inhibitors of the MDM2-p53 protein-protein interaction based on an isoindolinone scaffoldIan R Hardcastle, Shafiq U Ahmed, Helen Atkins, et al.
Journal of Medicinal Chemistry|November 18, 2010
DNA-dependent protein kinase (DNA-PK) inhibitors. Synthesis and biological activity of quinolin-4-one and pyridopyrimidin-4-one surrogates for the chromen-4-one chemotypeCéline Cano, Olivier R Barbeau, Christine Bailey, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Structure-based design of 2-arylamino-4-cyclohexylmethyl-5-nitroso-6-aminopyrimidine inhibitors of cyclin-dependent kinases 1 and 2Kerry L Sayle, Johanne Bentley, F Thomas Boyle, et al.
Journal of Medicinal Chemistry|July 26, 2002
Probing the ATP ribose-binding domain of cyclin-dependent kinases 1 and 2 with O(6)-substituted guanine derivativesAshleigh E Gibson, Christine E Arris, Johanne Bentley, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2002
4-Alkoxy-2,6-diaminopyrimidine derivatives: inhibitors of cyclin dependent kinases 1 and 2Veronique Mesguiche, Rachel J Parsons, Christine E Arris, et al.
Journal of Medicinal Chemistry|August 24, 2000
Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profilesC E Arris, F T Boyle, A H Calvert, et al.
Journal of Medicinal Chemistry|July 9, 2004
N2-substituted O6-cyclohexylmethylguanine derivatives: potent inhibitors of cyclin-dependent kinases 1 and 2Ian R Hardcastle, Christine E Arris, Johanne Bentley, et al.
Nature Structural Biology|September 24, 2002
Structure-based design of a potent purine-based cyclin-dependent kinase inhibitorThomas G Davies, Johanne Bentley, Christine E Arris, et al.
Pageof 20

Showing results (171-180 of 192) with videos related to

Sort By:
Pageof 20
Organic & Biomolecular Chemistry|June 16, 2007
Structure-based design of 2-arylamino-4-cyclohexylmethoxy-5-nitroso-6-aminopyrimidine inhibitors of cyclin-dependent kinase 2Francesco Marchetti, Kerry L Sayle, Johanne Bentley, et al.
ACS Combinatorial Science|July 12, 2016
High-Throughput Screening and Hit Validation of Extracellular-Related Kinase 5 (ERK5) InhibitorsStephanie M Myers, Ruth H Bawn, Louise C Bisset, et al.
Journal of Medicinal Chemistry|October 13, 2006
Small-molecule inhibitors of the MDM2-p53 protein-protein interaction based on an isoindolinone scaffoldIan R Hardcastle, Shafiq U Ahmed, Helen Atkins, et al.
Journal of Medicinal Chemistry|November 18, 2010
DNA-dependent protein kinase (DNA-PK) inhibitors. Synthesis and biological activity of quinolin-4-one and pyridopyrimidin-4-one surrogates for the chromen-4-one chemotypeCéline Cano, Olivier R Barbeau, Christine Bailey, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Structure-based design of 2-arylamino-4-cyclohexylmethyl-5-nitroso-6-aminopyrimidine inhibitors of cyclin-dependent kinases 1 and 2Kerry L Sayle, Johanne Bentley, F Thomas Boyle, et al.
Journal of Medicinal Chemistry|July 26, 2002
Probing the ATP ribose-binding domain of cyclin-dependent kinases 1 and 2 with O(6)-substituted guanine derivativesAshleigh E Gibson, Christine E Arris, Johanne Bentley, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2002
4-Alkoxy-2,6-diaminopyrimidine derivatives: inhibitors of cyclin dependent kinases 1 and 2Veronique Mesguiche, Rachel J Parsons, Christine E Arris, et al.
Journal of Medicinal Chemistry|August 24, 2000
Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profilesC E Arris, F T Boyle, A H Calvert, et al.
Journal of Medicinal Chemistry|July 9, 2004
N2-substituted O6-cyclohexylmethylguanine derivatives: potent inhibitors of cyclin-dependent kinases 1 and 2Ian R Hardcastle, Christine E Arris, Johanne Bentley, et al.
Nature Structural Biology|September 24, 2002
Structure-based design of a potent purine-based cyclin-dependent kinase inhibitorThomas G Davies, Johanne Bentley, Christine E Arris, et al.
Pageof 20